About
Titan Pharmaceuticals
Titan is advancing the treatment of select chronic diseases by developing therapeutics based on its proprietary long-term, continuous drug delivery platform, ProNeura.
More About Titan PharmaceuticalsProduct Pipeline
PROBUPHINE® (buprenorphine) Implant
for the treatment of Opioid Addiction
|
Market completed
|
Market completed
|
Market completed
|
Market completed
|
Market in progress
|
| Preclinical | Phase 1 | Phase 2 | Phase 3 | Market |
|---|
Product Pipeline
Ropinirole Implant
for the treatment of Parkinson's Disease
|
Phase 1 completed
|
Phase 1 in progress
|
Phase 1 not started
|
Phase 1 not started
|
Phase 1 not started
|
| Preclinical | Phase 1 | Phase 2 | Phase 3 | Market |
|---|
Product Pipeline
T3 Implant
for the treatment of Hypothyroidism
|
Preclinical in progress
|
Preclinical not started
|
Preclinical not started
|
Preclinical not started
|
Preclinical not started
|
| Preclinical | Phase 1 | Phase 2 | Phase 3 | Market |
|---|
Information for
Investors
Titan Pharmaceuticals, Inc.
Nasdaq: TTNP
Volume
Day Low/High
52-Week Low/High
Average Volume
Market Cap
August 13, 2020
A New View of the 3D Genome
